 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

U.S. stocks traded higher, with the Dow Jones gaining around 500 points on Tuesday.
Shares of Azenta, Inc. (NASDAQ: AZTA) rose on Tuesday after the company reported better-than-expected...

Azenta Reports Upbeat Earnings, Joins Talis Biomedical, Sally Beauty And Other Big Stocks Moving Higher On Tuesday

REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of...

Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash

Talis Biomedical Co. (NASDAQ:TLIS  Get Free Report) saw a significant decline in short interest in the month of August. As of August 31st, there was short interest totalling 14,000 shares, a...

Talis Biomedical Co. (NASDAQ:TLIS) Short Interest Update

Latest Ratings for TLIS
 DateFirmActionFromTo Jan 2022B of A SecuritiesDowngradesNeutralUnderperform Sep 2021JP MorganDowngradesNeutralUnderweight Aug 2021Piper SandlerDowngradesOverweightNeutral
 View More Analyst Ratings for TLIS

 View the Latest Analyst Ratings

read more...

BTIG Maintains Sell Rating for Talis Biomedical: Here's What You Need To Know

Talis Biomedical GAAP EPS of -$8.27 misses by $0.02, revenue of $0.58M beats by $0.47M

Conference call and webcast today at 4:30pm Eastern/1:30pm PacificREDWOOD CITY, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in...

Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update

REDWOOD CITY, Calif., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care (POC), today announced ...

Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)

REDWOOD CITY, Calif., July 24, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it...

Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price Requirement

Talis Biomedical to effect 1-for-15 reverse stock split to increase value of shares

Talis Biomedical Co. (NASDAQ:TLIS  Free Report) saw a large growth in short interest in June. As of June 15th, there was short interest totalling 258,600 shares, a growth of 42.4% from the May 31st total of 181,600 shares. Currently, 1.1% of the companys stock are short sold. Based on ...

Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company was founded on June 26, 2013 and is headquartered in Redwood City, CA.

Watchers	1,096
52-Wk Low	$4.35
52-Wk High	$9.75

Market Cap	$233.5M
Volume (M)	5,841.00
52-Wk High	$9.75
52-Wk Low	$4.35

TLIS Talis Biomedical Corp

About

Feed

News

Sentiment

Earnings

Fundamentals